Anna deFazio

Also affiliated with Westmead Hospital, Westmead Institute for Medical Research, Cancer Council NSW

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

13.3Author DataRank

Indexed papers

4in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Papers

Driven by 46 papers — median percentile 93. Top paper: “Pan-cancer analysis of whole genomes”.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

Cancer Research(2021)10.1158/0008-5472.can-21-0774

N/A

2.1DataRank · unranked

90 citations

Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo‐Yaw Ho +25 more

Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

British Journal of Cancer(2020)10.1038/s41416-020-0900-0

Top 10%

2.1DataRank

Top 10%68 citations

Dominique‐Laurent Couturier, Anna Paterson, Anthony N. Karnezis, Christine Chow, Tayyebeh M. Nazeran +92 more

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103

N/A

1.8DataRank · unranked

76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Modern Pathology(2020)10.1038/s41379-020-0618-9

N/A

1.3DataRank · unranked

43 citations

Dane Cheasley, Cécile Le Page, Matthew J. Wakefield, Michelle da Cunha Torres, Simone M. Rowley +93 more

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

The Journal of Pathology(2010)10.1002/path.2696

N/A

1.0DataRank · unranked

826 citations

Dariush Etemadmoghadam, Jillian Temple, Andy G. Lynch, Mohamed Riad, Raghwa Sharma +10 more

Profiling the immune landscape in mucinous ovarian carcinoma

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.022

N/A

0.993DataRank · unranked

26 citations

Phineas T. Hamilton, Katy Milne, Shelby Thornton, Bronwyn Harris, Ashley Weir +40 more

Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

Clinical Cancer Research(2009)10.1158/1078-0432.ccr-08-1564

N/A

0.858DataRank · unranked

303 citations

Anna deFazio, Rameen Beroukhim, Joshy George, Gad Getz, Richard Tothill +26 more

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311

Top 27%

0.751DataRank

Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019

N/A

0.718DataRank · unranked

119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3817

N/A

0.697DataRank · unranked

103 citations

Denise Chen, Rosario I. Corona, Zhuxuan Fu, Rajmohan Murali, Martin Köbel +33 more

The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3815

N/A

0.660DataRank · unranked

10 citations

Evan S. Cairns, Shelby Thornton, Bronwyn Harris, Katy Milne, Marcel Grube +23 more

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer

Journal of Clinical Investigation(2024)10.1172/jci179501

N/A

0.620DataRank · unranked

19 citations

Phineas T. Hamilton, Minh Tung Phung, Katy Milne, Bronwyn Harris, Shelby Thornton +73 more

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis

Cancers(2022)10.3390/cancers14081954

N/A

0.592DataRank · unranked

12 citations

Vladimir Djedovic, Susanne K. Kjær, Allan Jensen, Rosalind Glasspool, Patricia Roxburgh +24 more

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

UNC Libraries(2020)10.17615/c9kk-d491

N/A

0.517DataRank · unranked

4 citations

Martin Köbel, Hailei Zhang, Rehan Akbani, Nianxiang Zhang, Katherine A. Hoadley +27 more

Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac160

N/A

0.513DataRank · unranked

13 citations

Joe Dennis, Jonathan P. Tyrer, Pei-Chen Peng, Simon G. Coetzee, Alberto Luiz P. Reyes +94 more

Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.06.481

N/A

0.510DataRank · unranked

29 citations

Siri Peterson, Alice W. Lee, Bhramar Mukherjee, Kelly M. Bakulski, Aliya Alimujiang +46 more

The impact of coding germline variants on contralateral breast cancer risk and survival

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.02.003

N/A

0.500DataRank · unranked

27 citations

Nasim Mavaddat, Taru Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis +94 more

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.04.011

N/A

0.489DataRank · unranked

25 citations

Simon G. Coetzee, Jonathan P. Tyrer, Pei-Chen Peng, Will Rosenow, Stephanie Chen +95 more

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3552

N/A

0.453DataRank · unranked

14 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +93 more

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100042

N/A

0.434DataRank · unranked

17 citations

Daniel Considine, Jonathan P. Tyrer, Jasmine Plummer, Stephanie Chen, Felipe Segato Dezem +53 more

FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

European Journal of Human Genetics(2023)10.1038/s41431-022-01257-w

N/A

0.406DataRank · unranked

14 citations

Amandine Billaud, Thomas U. Ahearn, Natalia Antonenkova, Heiko Becher, Matthias W. Beckmann +95 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1817

N/A

0.396DataRank · unranked

13 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +62 more

Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.07.004

N/A

0.330DataRank · unranked

8 citations

Kyriaki Michailidou, Michael T. Parsons, Cristina Fortuño, Manjeet K. Bolla, Qin Wang +95 more

High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-21-0977

N/A

0.312DataRank · unranked

7 citations

Minh Tung Phung, Bhramar Mukherjee, Kelly M. Bakulski, Hoda Anton-Culver, Elisa V. Bandera +43 more

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

British Journal of Cancer(2022)10.1038/s41416-022-02014-y

N/A

0.312DataRank · unranked

7 citations

Eunyoung Kang, Nicola S. Meagher, Gregg Nelson, Prafull Ghatage, Cheng‐Han Lee +88 more

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies new candidate susceptibility genes for breast and ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.23.043653

N/A

0.292DataRank · unranked

6 citations

Daniel Considine, Jonathan P. Tyrer, Jasmine Plummer, Stephanie Chen, Felipe Segato Dezem +52 more

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

Canadian Journal of Surgery(2023)10.1503/cjs.017020

N/A

0.286DataRank · unranked

5 citations

Marcus Q. Bernardini, Stéphanie Lheureux, Katja K.H. Aben, Elisa V. Bandera, Matthias W. Beckmann +42 more

Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease

npj Genomic Medicine(2024)10.1038/s41525-024-00395-y

N/A

0.269DataRank · unranked

5 citations

Jonathan P. Tyrer, Stefan Kommoss, Anna deFazio, Marjorie J. Riggan, AOCS Group +75 more

Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

medRxiv(2023)10.1101/2023.11.09.23298321

N/A

0.269DataRank · unranked

5 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +94 more

Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

medRxiv(2021)10.1101/2021.09.16.21262993

N/A

0.241DataRank · unranked

4 citations

Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu +77 more

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk

medRxiv(2024)10.1101/2024.02.29.24303243

N/A

0.208DataRank · unranked

3 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.018

N/A

0.165DataRank · unranked

2 citations

Penelope M. Webb, Anna deFazio, Sián Fereday, Alice W. Lee, David D.L. Bowtell +25 more

Data from Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma

(2023)10.1158/0008-5472.c.6513498.v1

N/A

0DataRank · unranked

0 citations

Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo‐Yaw Ho +25 more

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

medRxiv(2023)10.1101/2023.03.20.23287465

N/A

0DataRank · unranked

9 citations

John J. Krais, Cassandra J. Vandenberg, Yifan Wang, Pooja Patel, Kathy Q. Cai +30 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.

Apollo (University of Cambridge)(2021)10.17863/cam.126709

N/A

0DataRank · unranked

0 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +65 more

Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer.

Apollo (University of Cambridge)(2021)10.17863/cam.74810

N/A

0DataRank · unranked

0 citations

Daniel Considine, Jonathan P. Tyrer, Jasmine Plummer, Stephanie Chen, Felipe Segato Dezem +53 more

Mathematical modeling of the evolution of resistance and aggressiveness of high-grade serous ovarian cancer from patient CA-125 time series

PLoS Computational Biology(2024)10.1371/journal.pcbi.1012073

N/A

0DataRank · unranked

5 citations

Jason I. Griffiths, Sián Fereday, Anna deFazio, David D.L. Bowtell, for Australian Ovarian Cancer Study +2 more

Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.10.419176

N/A

0DataRank · unranked

2 citations

Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo‐Yaw Ho +26 more

Therapeutic options for mucinous ovarian carcinoma

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.015

N/A

0DataRank · unranked

95 citations

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland, Prue E. Allan, Kathryn Alsop +35 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival

Annals of Oncology(2024)10.1016/j.annonc.2024.08.813

N/A

0DataRank · unranked

0 citations

Ahwan Pandey, Sián Fereday, R.J.B-N. Coelho, L.T. Twomey, Dinuka Ariyaratne +15 more

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.05.013

N/A

0DataRank · unranked

2 citations

Lauren Borho, Sarah E. Taylor, Linda E Kelemen, Anna deFazio, Penelope M. Webb +64 more

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

npj Genomic Medicine(2025)10.1038/s41525-025-00529-w

N/A

0DataRank · unranked

0 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Anna deFazio

Indexed papers

Top data-sharing exemplar

Papers